MannKind today announced six-month results from its Phase 3 INHALE-1 study of Afrezza insulin inhalation powder in children.

Call planned today at 8:30 a.m. (ET) to discuss company's diabetes program progression The INHALE-1 study is a 26-week, ...

MannKind (MNKD) announced six-month results from its Phase 3 INHALE-1 study of Afrezza Inhalation Powder in children and adolescents. MannKind ...

Purpose: The revised prescription drug labeling developed by the Food and Drug Administration (FDA) is described. Summary: A new FDA final rule, "Requirements on Content and Format of Labeling for ...

Project Renewal updates older oncology drug labels to ensure clinical relevance and scientific accuracy, involving external experts and early-career scientists. Fludarabine phosphate's updated label ...

The U.S. Food and Drug Administration and the U.S. Department of Agriculture have announced a joint request for Information (RFI) about food date labeling, which includes the use of terms such as ...

The FDA updated the fludarabine phosphate injection labeling under Project Renewal, clarifying the dosage for combination therapy and streamlining safety warnings. The FDA has approved an updated drug ...

The U.S. Food and Drug Administration (FDA) and the U.S. Department of Agriculture (USDA) announced a joint Request for Information (RFI) about food date labeling, which includes the use of terms such ...

A dairy state Senator remains critical of the Food and Drug Administration for failing to enforce dairy labeling standards. Tammy Baldwin from Wisconsin confronted FDA Commissioner Dr. Robert Califf ...

Drug maker Cipla on Wednesday said it has received approval from the Central Drugs Standard Control Organisation for the distribution and marketing of Afrezza inhalation powder in India. Afrezza, a ...

WASHINGTON, Dec. 3, 2024 – The U.S. Food and Drug Administration (FDA) and the U.S Department of Agriculture (USDA) today are announcing a joint Request for Information (RFI) about food date labeling, ...

A label begins with highlights, a succinct, half-page summary of the information that health care practitioners most commonly refer to and view as most important (Figure 2). [4] This section ...